Diagnostic performance of contrast-enhanced ultrasound using perfluorobutane for high-risk hepatocellular carcinoma
byAmerican Roentgen Ray Society(A) Arterial-phase CEUS image (12 seconds after injection) shows 25-mm segment-8 lesion with nonrim hyperenhancement (arrow). (B) CEUS image in portal-venous phase
Updated on: January 02,2024
8

Diagnostic performance of contrast-enhanced ultrasound using perfluorobutane for high-risk hepatocellular carcinoma
byAmerican Roentgen Ray Society(A) Arterial-phase CEUS image (12 seconds after injection) shows 25-mm segment-8 lesion with nonrim hyperenhancement (arrow). (B) CEUS image in portal-venous phase
Updated on:January 02,2024
8
